缩写名/全名 |
BREAST CANCER-TOKYO
Breast Cancer |
||||||||||||||||||||||||
ISSN号 | 1340-6868 | ||||||||||||||||||||||||
研究方向 | ONCOLOGY-OBSTETRICS & GYNECOLOGY | ||||||||||||||||||||||||
影响因子 | 2015:1.182, 2016:1.572, 2017:1.772, 2018:2.044, 2019:2.695, | ||||||||||||||||||||||||
出版国家 | JAPAN | ||||||||||||||||||||||||
出版周期 | |||||||||||||||||||||||||
年文章数 | 94 | ||||||||||||||||||||||||
出版年份 | 1994 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||
录用比例 | 容易 | ||||||||||||||||||||||||
投稿链接 | https://www.editorialmanager.com/brca/default.aspx | ||||||||||||||||||||||||
投稿官网 | http://link.springer.com/journal/12282 | ||||||||||||||||||||||||
h-index | 47 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1340-6868%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer Author: Lingxiao Pan, Changsheng Ye, Lun Chen, Wei Tang, Xiaoshen Zhang, Jin Gao, Rui Wu, Xigang Ye, Weige Tan, Minghui Wan, Wenbo Zheng Journal: Breast Cancer, 2019, Vol., , DOI:10.1007/s12282-019-00962-7 DOI |
2. | Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer Author: Lei Liu, Yunhui Hu, Sheng Zhang, Xiru Li, Jin Zhang Journal: Breast Cancer, 2019, Vol., , DOI:10.1007/s12282-018-00939-y DOI |
3. | Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla Author: Zhao Bi, Jingjing Liu, Peng Chen, Yanbing Liu, Tong Zhao, Chunjian Wang, Zhaopeng Zhang, Xiao Sun, Pengfei Qiu, Binbin Cong, Xianrang Song, Yongsheng Wang Journal: Breast Cancer, 2019, Vol., , DOI:10.1007/s12282-018-00934-3 DOI |
4. | Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis Author: Feng Chi, Rong Wu, Yuecan Zeng, Rui Xing, Yang Liu, Zhaoguo Xu Journal: Breast Cancer, 2012, Vol.20, 111-122, DOI:10.1007/s12282-012-0430-6 DOI |
5. | Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis Author: Qian Zhang, Jian Chen, Xiaoli Yu, Gang Cai, Zhaozhi Yang, Lu Cao, Chaosu Hu, Xiaomao Guo, Jing Sun, Jiayi Chen Journal: Breast Cancer, 2015, Vol.23, 732-739, DOI:10.1007/s12282-015-0631-x DOI |
6. | Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells Author: Yaojian Rao, Wei Xiong, Huijuan Liu, Chunxia Jia, Hongxing Zhang, Zesheng Cui, Ya Zhang, Jiawei Cui Journal: Breast Cancer, 2014, Vol.23, 216-223, DOI:10.1007/s12282-014-0553-z DOI |
7. | Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications Author: Jiqiao Yang, Qiuwen Tan, Qingyu Fu, Yaojie Zhou, Yuanyuan Hu, Shenli Tang, Yuting Zhou, Junhui Zhang, Juanjuan Qiu, Qing Lv Journal: Breast Cancer, 2016, Vol.24, 220-228, DOI:10.1007/s12282-016-0734-z DOI |
8. | Uncertainties remain in the status of internal mammary lymph nodes in breast cancers located in lower inner zone Author: Jiqiao Yang, Shenli Tang, Qing Lv Journal: Breast Cancer, 2017, Vol.24, 797-797, DOI:10.1007/s12282-017-0806-8 DOI |
9. | miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα Author: Ming Luo, Ling Ding, Qingjian Li, Herui Yao Journal: Breast Cancer, 2017, Vol.24, 673-682, DOI:10.1007/s12282-017-0756-1 DOI |
10. | The role of miR-130a in cancer Author: He-da Zhang, Lin-hong Jiang, Da-wei Sun, Jian Li, Zhen-ling Ji Journal: Breast Cancer, 2017, Vol.24, 521-527, DOI:10.1007/s12282-017-0776-x DOI |
|
|